Span-America Medical Systems (Span-America Medical Systems) Growth Rank : 0 (As of May. 05, 2024)

View and export this data going back to 1983. Start your Free Trial

What is Span-America Medical Systems Growth Rank?

Span-America Medical Systems has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Span-America Medical Systems Growth Rank Related Terms

Thank you for viewing the detailed overview of Span-America Medical Systems's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Span-America Medical Systems (Span-America Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Span-America Medical Systems Inc (NAS:SPAN) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.spanamerica.com

Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.

Executives

Terry Allison Rappuhn	director	P O BOX 58062, NASHVILLE TN 37205
Thomas Joseph Sullivan	director	64 PETTIT PL PRINCETON NJ 08540
Robert B Johnston	director

Span-America Medical Systems (Span-America Medical Systems) Headlines

From GuruFocus

SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 02-16-2010

Span-America (SPAN) – 2010 Review + Future Outlook

By asues asues • 01-21-2011

Span-America Medical Systems: 92nd Consecutive Dividend and Debt Free

By Mark Lin Mark Lin • 12-04-2012

SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q)

By gurufocus • 02-11-2009